Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Specific Antibody Deficiency”

18 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 18 of 18 results

Not applicableEnded earlyNCT02960399
What this trial is testing

Assessment of Immunogenicity of Zostavax® in Patients With Antibody Deficiency 60 Years of Age and Older

Who this might be right for
Common Variable Immune DeficiencySpecific Antibody DeficiencyX-linked Agammaglobulinemia
University of South Florida 2
Testing effectiveness (Phase 2)Looking for participantsNCT04319367
What this trial is testing

A Randomised Placebo Controlled Trial of ART Plus Dual Long-acting HIV-specific Broadly Neutralising Antibodies (bNAbs).

Who this might be right for
HIV/AIDS and Infections
Imperial College London 72
Testing effectiveness (Phase 2)Looking for participantsNCT05300035
What this trial is testing

Phase II Trial of ART + Dual bNAbs vs. ART + Placebo During Primary HIV-1 Infection-impact on Post-ART Control

Who this might be right for
HIV/AIDS and Infections
ANRS, Emerging Infectious Diseases 69
Not applicableLooking for participantsNCT06605378
What this trial is testing

Prevalence of Antibodies and Cytokines in Participants With Chronic Granulomatous Disease

Who this might be right for
Chronic Granulomatous Disease (CGD)
Ensoma 60
Testing effectiveness (Phase 2)Study completedNCT04871113
What this trial is testing

Evaluate the Antiviral Effect, Safety and Tolerability of GSK3810109A in Viremic Human Immunodeficiency Virus (HIV)-1 Infected Adults

Who this might be right for
HIV Infections
ViiV Healthcare 62
Not applicableStudy completedNCT03211689
What this trial is testing

The Impact of Exercise on Stress, Fatigue, and Quality of Life in Individuals With Primary Immunodeficiency Disease

Who this might be right for
Primary Immune Deficiency DisorderCommon Variable ImmunodeficiencySpecific Antibody Deficiency+1 more
Stockton University 36
Large-scale testing (Phase 3)Study completedNCT02013037
What this trial is testing

The De-novo Use of Eculizumab in Presensitized Patients Receiving Cardiac Transplantation

Who this might be right for
Antibody-mediated RejectionHyperacute Rejection of Cardiac TransplantLeft Ventricular Dysfunction+2 more
Cedars-Sinai Medical Center 36
Not applicableActive Not RecruitingNCT05321407
What this trial is testing

COVID-19 Vaccine Responses in PIDD Subjects

Who this might be right for
X-linked AgammaglobulinemiaXLAPrimary Immune Deficiency+4 more
Duke University 100
Not applicableStudy completedNCT00112593
What this trial is testing

Fludarabine and Total-Body Irradiation Followed By Donor Stem Cell Transplant and Cyclosporine and Mycophenolate Mofetil in Treating HIV-Positive Patients With or Without Cancer

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAcute Undifferentiated LeukemiaAdult Acute Lymphoblastic Leukemia in Remission+176 more
Fred Hutchinson Cancer Center 5
Not applicableEnded earlyNCT01883921
What this trial is testing

Gamma Globulin Observations and Outcomes Database for Patients With Primary Immunodeficiency Disease (GOOD-SHEPARD-PI)

Who this might be right for
Primary Immune Deficiency Disorder
BriovaRx Infusion Services 1,500
Testing effectiveness (Phase 2)Looking for participantsNCT06525298
What this trial is testing

EIS-12656 as Single Agent and in Combination in Patients With Specified Solid Tumors

Who this might be right for
Advanced Solid TumorHomologous Recombination DeficiencyHRR Deficiency
Eisbach Bio GmbH 144
Testing effectiveness (Phase 2)Study completedNCT02664415
What this trial is testing

Safety and Therapeutic Efficacy of the VRC01 Antibody in Patients Who Initiated Antiretroviral Therapy During Early Acute HIV Infection

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 23
Early research (Phase 1)Study completedNCT06585891
What this trial is testing

Study of a Human Bispecific Antibody VRC-HIVMAB0121-00-AB (CAP256J3LS) Administered Intravenously or Subcutaneously to Healthy Adults

Who this might be right for
HIV Infection
National Institute of Allergy and Infectious Diseases (NIAID) 24
Early research (Phase 1)Ended earlyNCT00006153
What this trial is testing

Effectiveness of Adding Remune to Your Current Anti-HIV Drug Combination

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 45
Early research (Phase 1)Study completedNCT00890747
What this trial is testing

Sunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral Therapy

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAcute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic SyndromeAcute Undifferentiated Leukemia+82 more
National Cancer Institute (NCI) 42
Not applicableLooking for participantsNCT05664035
What this trial is testing

Frequency of SPAD in Adult Patients

Who this might be right for
Specific Antibody DeficiencyPredominantly Antibody Deficiencies
University Hospital, Lille 99
Not applicableStudy completedNCT00661401
What this trial is testing

Specific IgG Antibody in Patients With Primary Antibody Deficiencies Treated With Subcutaneous Immunoglobulin

Who this might be right for
Common Variable ImmunodeficiencyAgammaglobulinemia
Federal University of São Paulo 5
Post-approval studies (Phase 4)Study completedNCT02429531
What this trial is testing

Polysaccharide Antibody Response Study

Who this might be right for
Specific Polysaccharide Antibody Deficiency
Universitaire Ziekenhuizen KU Leuven 200